Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADMS | TSHA | GBIO | ||
| Company | Adamas Pharma | Taysha Gene Therapies Inc | Generation Bio Co. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.24 | 2.65 | 3.28 | ||
| High | 8.25 | 2.75 | 3.36 | ||
| Low | 8.18 | 2.54 | 3.17 | ||
| Last | 8.22 | 2.57 | 3.17 | ||
| Change | +0.06 | -0.01 | +0.06 | ||
| % Change | +0.74% | -0.39% | +1.93% | ||
| Volume | 3,151,400 | 1,053,300 | 63,900 | ||
| 20-Day Average Volume | 834,440 | 1,851,930 | 214,925 | ||
| Previous Close | 8.16 | 2.58 | 3.11 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.16 | 2.59 | 3.25 | ||
| 20-Day Raw Stochastic | 86.36% | 33.86% | 25.82% | ||
| 20-Day Relative Strength | 73.46% | 50.86% | 50.68% | ||
| Weighted Alpha | +22.54 | +18.27 | +27.14 | ||
| Today's Opinion | 100% Buy | 40% Buy | 40% Buy | ||
| Previous Opinion | 96% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.86% since 11/16/21 | +7.53% since 04/26/24 | +9.31% since 04/26/24 | ||
| Low | 8.15 on 11/17/21 | 2.35 on 05/01/24 | 2.83 on 04/30/24 | ||
| High | 8.25 on 11/23/21 | 2.75 on 05/03/24 | 3.36 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | +2.62% since 10/22/21 | -5.51% since 04/03/24 | -23.06% since 04/03/24 | ||
| Low | 8.00 on 10/25/21 | 2.14 on 04/19/24 | 2.70 on 04/19/24 | ||
| High | 8.25 on 11/23/21 | 3.40 on 04/10/24 | 4.52 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | +77.54% since 08/23/21 | +70.20% since 02/02/24 | +72.28% since 02/02/24 | ||
| Low | 4.41 on 08/27/21 | 1.41 on 02/14/24 | 1.81 on 02/05/24 | ||
| High | 8.25 on 11/23/21 | 3.55 on 03/01/24 | 4.65 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +57.47% since 05/21/21 | +3.63% since 11/03/23 | +140.15% since 11/03/23 | ||
| Low | 4.02 on 08/16/21 | 1.27 on 11/14/23 | 1.02 on 11/09/23 | ||
| High | 8.25 on 11/23/21 | 3.55 on 03/01/24 | 4.65 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 376,369 | 482,506 | 206,781 | ||
| Shares Outstanding, K | 45,787 | 187,018 | 66,489 | ||
| Annual Sales | 74,460,000 | 15,450,000 | 5,900,000 | ||
| Annual Net Income | -57,400,000 | -111,570,000 | -126,610,000 | ||
| Last Quarter Sales | 25,900,000 | 3,600,000 | 2,880,000 | ||
| Last Quarter Net Income | -19,520,000 | 47,740,000 | -35,190,000 | ||
| 60-Month Beta | 2.82 | 0.37 | 2.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/10/21 | 0.35 on 03/19/24 | -0.53 on 03/06/24 | ||
| Latest Earnings Date | 11/11/21 | 05/09/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||